Monoclinic and triclinic concomitant polymorphs of di‐μ‐pyridazine‐1κ2N:2κ2N′‐bis­[(saccharinato)silver(I)]

Crystallization of the title compound, di‐μ‐pyridazine‐1κ²N:2κ²N′‐bis­(2,3‐dihydro‐3‐oxobenzisosulfonazolato‐κN)silver(I)], Ag₂(C₇H₄NO₃S)₂(C₄H₄N₂)₂], from acetonitrile yields both monoclinic, (I), and triclinic, (II), polymorphs. In both forms, the silver(I) ions have a slightly distorted trigonal AgN₃ coordination geometry and are doubly bridged by two neutral pyridazine (pydz) ligands, generating a centrosymmetric dimeric structure. The saccharinate (sac) ligands are N‐coordinated. The dihedral angles between the sac and pydz rings are 8.43 (7) and 7.94 (8)° in (I) and (II), respectively, suggesting that the dimeric mol­ecule is nearly flat. The bond geometry is similar in both polymorphs. In (I), the dimers inter­act with each other via aromatic π_sac–π_pydz stacking inter­actions, forming two‐dimensional layers, which are further crosslinked by weak C—H?O inter­actions. Compound (II) exhibits similar C—H?O and π–π inter­actions, but additional C—H?π and π?Ag inter­actions help to stabilize the packing of the dimers.